Generally speaking, most people today either know someone dealing with depression, or have struggled with depression themselves. While many individuals can be successfully treated by a combination of medication or talk therapy, there are some who continue to experience symptoms after trying several treatments. Recent research has highlighted ketamine as a potential treatment for treatment-resistant […]
The REVIVE clinical trial team is seeking feedback from the public on their study testing the use of RESQFOAM in severely injured trauma patients.
Thirty-six minutes. That is the average time it takes for a person who has entered a hospital’s emergency department to reach an operating room. For a patient suffering from an exsanguinating, noncompressible abdominal hemorrhage – a severe, life-threatening trauma – that is 36 minutes of continued blood loss. What if there was a way to […]
Researchers at Massachusetts General Hospital have developed a new technique for imaging the brains of patients with amyotrophic lateral sclerosis (ALS) that could vastly reduce the cost and time needed for new clinical trials—while also improving the accuracy of test results. Nazem Atassi, MD, the Associate Director of the Neurological Clinical Research Institute (NCRI) at […]
When a patient has strep throat, their care provider knows which antibiotics to prescribe to cure the ailment. But when a disease has no known cure, as is the case with amyotrophic lateral sclerosis (ALS), research often becomes part of clinical care. “There are still a lot of limitations in terms of what we can […]
Technological advancements have revolutionized nearly every field of medicine from orthopedics to genetic testing. Sabrina Paganoni, MD, PhD, a clinician and researcher in the Neurological Clinical Research Institute (NCRI) at Massachusetts General Hospital, has seen firsthand the potential power and impact technology could have for amyotrophic lateral sclerosis (ALS). Paganoni is using technology to find […]
May is ALS Awareness Month, intended as a time to raise awareness of and foster research for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually these motor neurons die, effecting a patient’s ability to move, eat, […]
Mass General researchers recently published an article detailing a new treatment for a dangerous swelling condition called Hereditary angioedema.